糖尿病患者血压控制与心血管疾病的预防

被引:9
作者
孙纪新
杨华英
机构
[1] 河北省疾病预防控制中心慢性病防治科
[2] 河北省疾病预防控制中心心血管病防治科
关键词
糖尿病患者; 非糖尿病; 安慰剂; β受体; 空白剂; β型肾上腺素能受体; 心血管疾病; 胰岛素抵抗; 胰岛素信号传导; 糖尿病组; 血压控制; 阻滞剂; 森林阻火剂;
D O I
暂无
中图分类号
R587.1 [糖尿病]; R54 [心脏、血管(循环系)疾病];
学科分类号
摘要
引用
收藏
页码:928 / 930
页数:3
相关论文
共 22 条
[1]  
Use of ramipril in preventing stroke:double blind randomized trial. Bosch J,Yusuf S,Pogue J,et al. British Medical Journal . 2002
[2]  
Imadapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. Nawano M,Anai M,Funaki M,et al. Metabolism . 1999
[3]  
UK Prospective Diabetes Study 38: tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS Group. British Medical Journal . 1998
[4]  
Effects of intensive blood pressure- lowering and low- dose asprin in patients with hypertension:principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Hansson L,Zanchetti A,Carrthers SG,et al. The Lancet . 1998
[5]  
Effetes of calcium channel blockers in older patients with diabetes and systolic hypertension. Tuomilehto J,Rastenyte D,Birkenhager WH,et al. The New England Journal of Medicine . 1999
[6]  
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated hypertension. Curb JD,Pressel MS,Cutler JA,et al. The Journal of The American Medical Association . 1996
[7]  
Potentiating of bradykinin action by ACE inhibitiors. Eros EG,Deddish PA,Marcic BM. Trends in Endocrinology and Metabolism . 1999
[8]  
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Hansson L,Lindholm LH,Niskanen L,et al. The Lancet . 1999
[9]  
ACE inhibition and glucose transport in insulin resistant muscle: role of brandykinin and nitric oxide. Henriksen EJ,Jacob S,Kinnick TR,et al. American Journal of Physiology . 1999
[10]  
AngiotensinⅡAT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Leszek Kalinowski,Tomasz Matys,Ewa Chabielska,et al. Journal of Hypertension . 2002